{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:25:51Z","timestamp":1786994751698,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuint.2013.02.017","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:10:47Z","timestamp":1361470247000},"page":"870-872","source":"Crossref","is-referenced-by-count":7,"title":["Expression and differential response to haloperidol treatment of Cyclon\/CCDC86 mRNA in schizophrenia patients"],"prefix":"10.1016","volume":"62","author":[{"given":"Trifon","family":"Chervenkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Shishkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton B.","family":"Tonchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2013.02.017_b0005","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.conb.2010.09.008","article-title":"The neurobiology of schizophrenia: new leads and avenues for treatment","volume":"20","author":"Bray","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuint.2013.02.017_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.mp.4001932","article-title":"Interleukin 3 and schizophrenia: the impact of sex and family history","volume":"12","author":"Chen","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.02.017_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.2007.07121868","article-title":"Interleukin 3 and schizophrenia","volume":"165","author":"Chen","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuint.2013.02.017_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/15622975.2010.544328","article-title":"Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population","volume":"12","author":"Chen","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.02.017_b0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5272\/jimab.2012183.276","volume":"18","author":"Chervenkov","year":"2012","journal-title":"J. IMAB"},{"key":"10.1016\/j.neuint.2013.02.017_b0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1515\/cclm-2011-0684","article-title":"Schizophrenia is associated with increased levels of serum Fas and FasL","volume":"50","author":"Djordjevi\u0107","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neuint.2013.02.017_b0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.febslet.2007.01.083","article-title":"Redundant promoter elements mediate IL-3-induced expression of a novel cytokine-inducible gene, cyclon","volume":"581","author":"Hoshino","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2013.02.017_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2013.02.017_b0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157339510791823673","article-title":"Immune system and schizophrenia","volume":"6","author":"M\u00fcller","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.neuint.2013.02.017_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-12-398314-5.00003-9","article-title":"Inflammation in schizophrenia","volume":"88","author":"M\u00fcller","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.neuint.2013.02.017_b0055","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood-2008-11-189118","article-title":"Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon","volume":"114","author":"Saint Fleur","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.neuint.2013.02.017_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0278-5846(94)00106-R","article-title":"Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients","volume":"19","author":"Sirota","year":"1995","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.02.017_b0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00406-010-0098-x","article-title":"Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity","volume":"260","author":"Steiner","year":"2010","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuint.2013.02.017_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2008.05.029","article-title":"Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population","volume":"440","author":"Sun","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2013.02.017_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.02.071","article-title":"A family-based study of the IL3RA gene on susceptibility to schizophrenia in a Chinese Han population","volume":"1268","author":"Sun","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2013.02.017_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","article-title":"Schizophrenia, \u201cjust the facts\u201d 5. Treatment and prevention. Past, present, and future","volume":"122","author":"Tandon","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuint.2013.02.017_b0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.schres.2008.09.001","article-title":"Altered interleukin-3 serum levels in drug-na\u00efve and neuroleptic-treated schizophrenic patients","volume":"106","author":"Xiu","year":"2008","journal-title":"Schizophr. Res."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T20:45:08Z","timestamp":1562705108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018613000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0197018613000624"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2013.02.017","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}